7 EHR-to-EDC Trends Transforming Global Clinical Trials in 2025

In 2025, EHR-to-EDC automation is reshaping how sponsors, CROs, and research sites manage clinical data.

EHR-to-EDC data integration for global clinical trials – Yonalink platform screenshot.

The Era of Automated Data Flow

Manual transcription from electronic health records (EHRs) to electronic data capture (EDC) systems has long been a source of cost, delay, and error in clinical trials.

In 2025, that bottleneck is finally breaking.

Across sponsors, CROs, and site networks, EHR-to-EDC automation is shifting from early adoption to expected standard, powered by interoperability frameworks like FHIR, greater regulatory confidence, and proven ROI.

Trend #1: FHIR Becomes the Common Language

FHIR (Fast Healthcare Interoperability Resources) has matured from a promising standard into the backbone of EHR-EDC connectivity.

Major EHR systems including Epic, Cerner, Allscripts, and others, now offer FHIR-based APIs, enabling vendors like Yonalink to stream structured data directly into EDCs.

As sponsors demand higher data quality and faster insights, FHIR compliance is increasingly seen as a prerequisite for site readiness.

Trend #2: Sponsors Demand Real-Time Visibility

Trial sponsors and data managers no longer want to wait days or weeks to view site-level updates.

EHR-to-EDC technology enables near real-time monitoring of patient status, visit completion, and data quality.

This shift is fueling adoption among global pharma and biotech firms seeking faster database locks and earlier interim analyses - outcomes that were difficult to achieve with manual workflows.

Trend #3: AI and Automation Extend the Impact

Artificial intelligence is now being layered on top of EHR-to-EDC pipelines.

AI models assist in data mapping, anomaly detection, and even predictive query management, reducing manual oversight and boosting accuracy.

Combined with automation, this creates a closed-loop data flow where source data verification (SDV) time and query rates continue to decline.

Trend #4: Regulatory Confidence Grows Worldwide

For years, regulatory hesitation slowed adoption.

That’s changing quickly.

In the United States, the FDA’s Digital Health Technologies guidance and updated Part 11 expectations have clarified acceptable approaches for EHR-to-EDC integration.

In Europe, EMA’s push toward eSource adoption under Good Clinical Practice (GCP) modernization is accelerating pilots.

Even in emerging regions, sponsors are leveraging global frameworks (HIPAA, GDPR, ISO 27001) to ensure compliant data flow across borders.

Trend #5: Sites Demand Relief from Data Burden

Site coordinators consistently report that data entry consumes over 30% of trial time.

As staffing shortages persist, automated data flow from EHRs to EDCs is becoming a differentiator for site participation.

Networks and academic research organizations are now proactively seeking partnerships with vendors offering secure, validated, and low-friction integration.

Trend #6: Integration Ecosystems Expand Beyond the EDC

While the term “EHR-to-EDC” remains central, the underlying technology is evolving into broader EHR-to-Anywhere streaming.

Forward-looking sponsors now route data not just to EDCs, but also to data lakes, real-world evidence platforms, and AI-ready repositories.

Yonalink’s architecture, for example, supports multi-destination data streaming - ensuring the same validated dataset can power analytics across the trial lifecycle.

Trend #7: Proof of ROI Drives Executive Buy-In

Early adopters are publishing measurable outcomes:

  • 60–70% reduction in SDV effort
  • Up to 50% faster data entry
  • Fewer transcription errors and protocol deviations

As more CROs and sponsors quantify the gains, EHR-to-EDC integration is shifting from a “nice-to-have” to a budgeted line item in digital trial strategies.

The Road Ahead

By the end of 2025, industry analysts predict that more than half of new interventional trials will incorporate some level of automated EHR data capture.

The remaining challenge is scale. I.e. expanding beyond pilot programs to global, multi-site deployments that respect local privacy laws and diverse EHR ecosystems.

Vendors that balance compliance, interoperability, and usability will define the next era of connected clinical research.

Conclusion: A New Standard for Global Trials

EHR-to-EDC automation has matured from innovation to infrastructure.

In a world where trial efficiency and data integrity are non-negotiable, automation is the bridge connecting sites, sponsors, and patients.

→ Download our 2025 EHR-to-EDC Benchmark Report to explore adoption metrics, ROI data, and expert insights from across North America and beyond.

Continue Reading

Infographic illustrating key insights from the EHR-to-EDC Automation Benchmark Report 2025, showing global trends, adoption growth, ROI improvements, and data-quality metrics in clinical trial automation.

EHR-to-EDC Automation Benchmark Report 2025: Global Trends and Insights

EHR-to-EDC automation is transforming clinical trials - reducing site burden and improving data quality worldwide.
Alicia Mintz
Alicia Mintz
October 23, 2025
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.